References
- Glimelius B. Progress in oncology and progress for Acta Oncologica. Acta Oncol 2005; 44: 9–10
- Glimelius B. Acta Oncologica: Greater attractiveness. Acta Oncol 2003; 42: 799
- Lax I. Target dose versus extratarget dose in stereotactic radiosurgery. Acta Oncol 1993; 32: 453–7
- Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995; 34: 861–70
- Grau C, Hoyer M, Lindegaard J, Overgaard J. The emerging evidence for Stereotactic Body Radiotherapy. Acta Oncol 2006; 45: 771–4
- Okunieff P. Design of multi-institutional and cooperative group studies of SBRT. Acta Oncol 2006; 45: 775–8
- Johansson S. Radiation induced brachial plexopathies. Acta Oncol 2006; 45: 253–7
- Galecki J, Hicer-Grzenkowicz J, Grudzien-Kowalska M, Michalska T, Zalucki W. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer–a review. Acta Oncol 2006; 45: 280–4
- Lind P. Clinical relevance of pulmonary toxicity in adjuvant breast cancer irradiation. Acta Oncol 2006; 45: 13–5
- Jarvenpaa R, Holli K, Pitkanen M, Hyodynmaa S, Rajala J, Lahtela SL, et al. Radiological pulmonary findings after breast cancer irradiation: A prospective study. Acta Oncol 2006; 45: 16–22
- Dasu A, Toma-Dasu I, Olofsson J, Karlsson M. The use of risk estimation models for the induction of secondary cancers following radiotherapy. Acta Oncol 2005; 44: 339–47
- Glimelius, B. Rectal cancer irradiation. Long course, short course or something else?. Acta Oncol 2006;45:1013–7.
- Horsman MR, Nielsen T, Ostergaard L, Overgaard J. Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response. Acta Oncol 2006; 45: 876–80
- Glimelius B, Ask A, Bjelkengren G, Björk-Eriksson T, Blomquist E, Johansson B, et al. Number of patients potentially eligible for proton therapy. Acta Oncol 2005; 44: 836–849
- Bjelkengren G, glimelius B. The potential of proton beam radiation therapy in lung cancer (including mesothelioma). Acta Oncol 2005; 44: 881–883
- Björk-Eriksson T, Ask A, Glimelius B. The potential of proton beam radiation for palliation and reirradiation. Acta Oncol 2005; 44: 918–920
- Björk-Eriksson T, Bjelkengren G, Glimelius B. The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma. Acta Oncol 2005; 44: 913–917
- Björk-Eriksson T, Glimelius B. The potential of proton beam radiation therapy in paediatric cancer. Acta Oncol 2005; 44: 871–875
- Björk-Eriksson T, Glimelius B. The potential of proton beam radiation therapy in breast cancer. Acta Oncol 2005; 44: 884–889
- Ask A, Björk-Eriksson T, Zackrisson B, blomquist E, glimelius B. The potential of proton beam radiation therapy in head and neck cancer. Acta Oncol 2005; 44: 876–880
- Ask A, Johansson B, Glimelius B. The potential of proton beam radiation therapy in gastrointestinal cancer. Acta Oncol 2005; 44: 896–903
- Blomquist E, Bjelkengren G, Glimelius B. The potential of proton beam radiation therapy in intracranial and ocular tumours. Acta Oncol 2005; 44: 862–870
- Johansson B, Ridderheim M, Glimelius B. The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers. Acta Oncol 2005; 44: 890–895
- Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol 2006; 80: 263–7
- Yock T, Schneider R, Friedmann A, Adams J, Fullerton B, Tarbell N. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys 2005; 63: 1161–8
- Kozak KR, Katz A, Adams J, Crowley EM, Nyamwanda JA, Feng JK, et al. Dosimetric comparison of proton and photon three-dimensional, conformal, external beam accelerated partial breast irradiation techniques. Int J Radiat Oncol Biol Phys 2006; 65: 1572–8
- Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006; 65: 1087–96
- Weber DC, Bogner J, Verwey J, Georg D, Dieckmann K, Escude L, et al. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study. Int J Radiat Oncol Biol Phys 2005; 63: 373–84
- Lee CT, Bilton SD, Famiglietti RM, Riley BA, Mahajan A, Chang EL, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?. Int J Radiat Oncol Biol Phys 2005; 63: 362–72
- Goitein M, Goitein G. Swedish protons. Acta Oncol 2005; 44: 793–797
- Dahl O. Protons. A step forward or perhaps only more expensive radiation therapy?. Acta Oncol 2005; 44: 798–800
- Karlsson, M, Björk-Eriksson, T, Mattsson, O, Mattsson, S, Montelius, A, Nilsson, P, et al. Distributed proton radiation therapy-A new concept for advanced competence support. Acta Oncol 2006;45, ?-?
- Lundkvist J, Ekman M, Rehn Ericsson S, Jönsson B, Glimelius B. Proton therapy of cancer: Potential clinical advantages and cost-effectiveness. Acta Oncol 2005; 44: 850–861